首页> 外文期刊>International journal of fertility and women's medicine >Minimal requirements for a successful outcome in anovulatory patients treated with human menopausal gonadotropins.
【24h】

Minimal requirements for a successful outcome in anovulatory patients treated with human menopausal gonadotropins.

机译:对于使用人类更年期促性腺激素治疗的无排卵患者,成功治疗的最低要求。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: To determine the minimal requirements for achieving a full-term singleton pregnancy in hMG-treated patients. METHODS: One hundred and ninety-two pregnancy cycles resulting from hMG therapy in infertile patients were retrospectively studied to determine the minimal requirements for the occurrence of a pregnancy in those women. The cycles were divided into five groups: pregnancies ending in miscarriage, ectopic pregnancies, pregnancies ending in preterm delivery, full-term singleton pregnancies, and full-term multiple pregnancies. The number of hMG ampules, the number of preovulatory follicles reaching 18 mm or more in diameter, the cervical mucus score (Insler), the number of living spermatozoa per high-power field (HPF) observed in the cervical mucus on the day of hCG administration, and the midluteal plasma progesterone concentration were determined and correlated with the outcome of the pregnancy in the five groups studied. The minimal requirements for the occurrence of a full-term singleton pregnancy were also determined. RESULTS: In this cohort of 192 women, the mean number of hMG ampules administered was 25.38 (1903.5 IU), the mean number of preovulatory follicles reaching 18 mm was 2.1, the mean cervical mucus score (Insler) was 9.48, and the mean number of motile spermatozoa per HPF in the cervical mucus on the day of hCG administration was 19.3. There were no statistically significant differences between the five groups studied regarding these four variables. The mean midluteal plasma progesterone concentration was 29.07 ng/mL and there was no statistically significant difference in midluteal plasma progesterone concentration between the cycles resulting in full-term deliveries and those ending in miscarriage. However, a statistically significant difference in midluteal plasma progesterone concentration was found between the cycles resulting in full-term singleton pregnancies and those resulting in full-term multiple pregnancies. CONCLUSIONS: The minimal requirements for achieving a full-term singleton pregnancy were 9 ampules of hMG (675 IU), one 18-mm follicle, a cervical mucus score (Insler) of 6 on the day of hCG administration, and a midluteal plasma progesterone concentration of 10.83 ng/mL. The presence of motile spermatozoa in the cervical mucus was a reassuring sign in 92.7% of instances but was not an absolute necessity for a successful outcome.
机译:目的:确定在接受hMG治疗的患者中实现单胎妊娠的最低要求。方法:回顾性研究了hMG治疗不孕症患者产生的192个妊娠周期,以确定这些妇女发生妊娠的最低要求。这些周期分为五组:以流产结束的妊娠,异位妊娠,以早产结束的妊娠,足月单胎妊娠和足月多次妊娠。在hCG当天,在宫颈粘液中观察到的hMG安瓿数量,直径达到18 mm或更大的排卵前卵泡数量,宫颈粘液评分(Insler),每个高倍视野(HPF)的活精子数量。在研究的五组中,确定了经皮注射的剂量,确定了中臀血浆孕酮浓度,并将其与妊娠结局相关联。还确定了发生足月单胎妊娠的最低要求。结果:在这192名妇女队列中,平均给予hMG安瓿数量为25.38(1903.5 IU),排卵前卵泡平均数量为18 mm为2.1,平均宫颈粘液得分(Insler)为9.48,平均数量给予hCG时,宫颈粘液中每个HPF的活动性精子为19.3。在这四个变量之间,研究的五组之间没有统计学上的显着差异。导致足月分娩的周期与以流产结束的周期之间,平均中臀血浆孕酮浓度为29.07 ng / mL,中臀血浆孕酮浓度在统计学上无显着差异。然而,在导致足月单胎妊娠和导致足月多胎妊娠的两个周期之间,发现中臀血浆孕酮浓度存在统计学上的显着差异。结论:要获得足月单胎妊娠的最低要求是:9安瓿hMG(675 IU),1个18毫米卵泡,hCG给药当天宫颈黏液评分(Insler)为6,以及黄体中期血浆孕酮浓度为10.83 ng / mL。宫颈粘液中能活动的精子的存在使92.7%的情况令人放心,但并不是取得成功结局的绝对必要条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号